Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab Plus Gossypol Acetate in Advanced pMMR/MSS Colorectal Cancer
NCT07656766Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab, gossypol acetate in colorectal cancer (CRC), sponsored by Peking University People's Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
sintilimabgossypol acetate
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07656766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07656766.